T Cell and Interferon Expression in Tonsils After Sublingual Immunotherapy and/or Nasal Live Attenuated Influenza Vaccine

Trial Profile

T Cell and Interferon Expression in Tonsils After Sublingual Immunotherapy and/or Nasal Live Attenuated Influenza Vaccine

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary) ; Influenza virus vaccine live (Primary)
  • Indications Allergic asthma; Grass pollen hypersensitivity; Influenza virus infections
  • Focus Pharmacodynamics
  • Acronyms Tons2
  • Most Recent Events

    • 12 Dec 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2013-000492-32)
    • 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 21 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top